Back
Catalyst Pharmaceuticals Stock Predictions
Sponsored
CPRX
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
57
CPRX
Catalyst Pharmaceuticals
Last Price:
21.95
Seasonality Move:
-2.02%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeCatalyst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 31.9% based on the past 17 years of stock performance.
- Catalyst Pharmaceuticals has risen higher in 11 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%
-
Is Catalyst Pharmaceuticals Stock Undervalued?
The current Catalyst Pharmaceuticals [CPRX] share price is $21.96. The Score for CPRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. - CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 31.9% based on the past 17 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Buy
57
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals overpriced?
- Catalyst Pharmaceuticals has risen higher in 11 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
22.27
52-Week Low:
12.27
Prediction Charts
Market Cap:
2.61B
Price in USD:
21.96
Volume:
872.46K
Beta:
1.10
Technical Analysis
SMA50:
20.55
SMA100:
18.78
SMA200:
17.06
52-Wk Change:
66.87%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?
Yes, Catalyst Pharmaceuticals is a publicly traded company. -
What is the Catalyst Pharmaceuticals stock quote today?
The Catalyst Pharmaceuticals stock price is 21.96 USD today. -
How to buy Catalyst Pharmaceuticals stock online?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 21.20 | 21.67 | 21.85 | 21.02 |
Oct-18 | 21.17 | 21.24 | 21.49 | 21.12 |
Oct-21 | 21.35 | 21.02 | 21.38 | 20.87 |
Oct-22 | 20.88 | 21.46 | 21.48 | 20.81 |
Oct-23 | 21.46 | 21.34 | 21.62 | 21.02 |
Oct-24 | 21.37 | 21.41 | 21.62 | 21.11 |
Oct-25 | 21.50 | 21.46 | 21.93 | 21.42 |
Oct-28 | 21.76 | 21.87 | 22.20 | 21.67 |
Oct-29 | 21.77 | 21.77 | 22.20 | 21.56 |
Oct-30 | 21.72 | 21.59 | 21.91 | 21.49 |
Oct-31 | 21.42 | 21.80 | 21.95 | 21.20 |
Nov-1 | 21.77 | 21.89 | 22.27 | 21.68 |
Nov-4 | 21.82 | 21.74 | 21.96 | 21.30 |
Nov-5 | 21.57 | 21.96 | 22.05 | 21.41 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.